<unk>  is indicated in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer following docetaxel-based treatment.
Cabazitaxel
Docetaxel
Paclitaxel
Doxorubicin
Ifosfamide
Lipoplatin
Bendamustine
Normustine